Jump to content
Chapala.com Webboard

gimpychimp

Members
  • Posts

    530
  • Joined

  • Last visited

  • Days Won

    4

gimpychimp last won the day on April 23 2018

gimpychimp had the most liked content!

Contact Methods

  • Website URL
    http://
  • ICQ
    0

Profile Information

  • Location
    Ajijic

Recent Profile Visitors

7,179 profile views

gimpychimp's Achievements

Newbie

Newbie (1/14)

  • Week One Done Rare
  • One Month Later Rare
  • One Year In Rare

Recent Badges

427

Reputation

  1. Why didn't you just go to one of the many municipalities comprising the greater Guadalajara area and get one? They were happy to give one to anyone over 60. Soon they will be happy to give one to anyone over 50.
  2. I feel certain that just as the last dose was advertised as being for those 60 years old at minimum, the next round will be advertised as being for those 50 years old at minimum. They definitely want anyone older to get the shot and this is the sensible way to keep getting any older residents to come in for the shot. This way anyone who is above the age limit can join in. The Federal Government makes all the decisions about the vaccine program so no one locally will be able to cause any changes to whatever they plan, but this situation of those who missed their first chance will be country wide so this is surely the way they will cover those people too.
  3. Wouldn't it have been a lot easier to drive into Guadalajara and get the shot if you don't like the one they are offering in Chapala?
  4. I read elsewhere that the tag actually says "Bob and Judy Katz".
  5. If a student doesn't get into the University of Guadalajara on the first try, they can try again every 6 months. I have sponsored students who got in on their third try to medical school, which is the hardest faculty to get into, with a huge number of applicants each semester. The entrance is decided by taking the student's average in Prepa, which is what we think of as high school, and adding it to a number they achieve on an entrance exam they write. The students I speak of had an average of 99% in the public Prepa, but didn't get a high enough number on the entrance exam to be accepted to the Guadalajara campus which they had to choose ahead of time. In one case a girl missed the number by less than half a percent, so next time she applied to Tonala campus instead of Guadalajara and she made it. You need a little bit lower of a score to get into the other campuses like Tonala, Ocotlan, Cd. Guzman, etc. I had another student with 99% in Prepa who didn't get into medical school after 2 attempts so he decided to go to a private university in Guadalajara, named Lamar, where he pays 3000p a month for tuition. I know MANY students who were accepted to UdeG, who attended the public Prepas in Jocotepec and Chapala, which is where all the kids from Lakeside who can't afford private schools attend Prepa. For a determined student who is willing to put in the work, the education is indeed available there and private school is not required. Some of the public Prepa educated students went through medical school and graduated with averages there in the 90's as well, which is not easy. A truly good student will do very well without attending private schools or universities here. There are also courses available privately for a couple of thousand pesos, which a number of the students took, to teach them tips and tricks for how to do best on the university entrance exam.
  6. An excellent painter is Enrique Pineda and his crew. Call 333 440 6364. He provides a 5 year warranty on his work too. His English is excellent.
  7. The University of Guadalajara charges a very low inscription fee each semester of about 800 to 1000 pesos, and that covers tuition for the whole semester. As a public university his education there is considered to be free from the government. There are 2 semesters each school year. The biggest expense for students from lakeside is that they either must rent a room in the city, or else ride the bus back and forth every day which costs at least as much. Renting a room varies depending on location and is usually about 1500 to 2500p a month. Books are quite minimal and some teachers let the students use downloaded ones. In general about 15000 pesos covers all expenses for the whole semester of 5 months. If the student goes to a University of Guadalajara campus in a smaller location instead of Guadalajara, such as Ocotlan or Ciudad Guzman, the rents are often cheaper than what they are in Guadalajara. He will need very high marks to be accepted there.
  8. The government will be supplying the young students with uniforms and backpacks, etc. The parents of primary school students pay a very small inscription fee (no more than 300p) to register the child in the school. Here is a video of the Governor explaining it, in Spanish. https://fb.watch/5aKaIArEKd/
  9. Yes they want to open the schools in May if possible. They can't be snubbing those over 65 if they are doing second shots for Jocotepec "over 60s" this week, can they? They have to work with whatever number of each vaccine they can get and supply is low in many countries, not just Mexico. Be patient and your turn will come. It is the Federal Government who is doing all the "planning".
  10. My friends who got their shots at the drive through in Tonalá about a month ago received a call from an English speaking person a few days ago, to advise them to come yesterday for their second shots. They went and it was very simple and they received some documentation showing that they had received both shots. Maybe Lakeside people will get calls too, I hope.
  11. First Dose of Chinese Covid-19 Vaccine Offers Little Protection, Chile Learns The country vaccinated at record clip with shots developed by China’s Sinovac, then cases and deaths rose. Health experts say Chile dropped precautions too soon. A healthcare worker administered a Covid-19 vaccine dose at a church in Valparaíso, Chile, this month. Photo: Javier Torres/Agence France-Presse/Getty Images By Ryan Dube Updated April 18, 2021 7:26 pm ET Several days after receiving his first dose of a Chinese-made coronavirus vaccine, Rodrigo Jordán fell ill and tested positive for Covid-19. The 61-year-old was hospitalized near his home in the Chilean capital, Santiago, for nine days and needed supplemental oxygen to pull through. Across Chile—which has mounted one of the world’s most rapid vaccination campaigns using the vaccine made by Chinese drugmaker Sinovac Biotech Ltd.—health authorities are scrambling to deal with a surge in new infections and deaths. More than 7.6 million people, half of Chile’s adult population, have already received at least one vaccine dose, most made by the Chinese drugmaker, making the country a real-world testing ground for a vaccine that Beijing is supplying to countries across the developing world. The problem, public-health officials say, was that people in general overestimated the effectiveness of the vaccine after only one of the two recommended doses and moved to ease up on pandemic-control restrictions too soon. “With one dose, we know the protection is very weak,” said Claudia Cortés, an infectious disease expert at the Santa Maria Clinic in Santiago, where about 10% of the Covid-19 patients at her hospital have received one shot. “It was not clearly explained that you need two doses—that you need to wait.” It is a cautionary tale for other countries—from Brazil to Colombia in Latin America; Turkey to Indonesia in other corners of the globe—that have started to roll out the Sinovac vaccine. On Friday, Chilean authorities released the results of a study of 10.5 million people, showing the vaccine was 16% effective against infection after one dose and 67% effective after a second dose. The study also found it to be 80% effective in preventing death from Covid-19 two weeks after a second dose. A vaccination center at a Santiago stadium last month. Chilean officials are weighing whether a third dose of China’s CoronaVac vaccine may be needed. Photo: Matias Basualdo/Zuma Press That is lower than the vaccine made by Pfizer Inc. and BioNTech SE, for example. Research published in February in the Lancet medical journal found that one dose of the Pfizer and BioNTech vaccine was 85% effective in preventing symptomatic disease 15 to 28 days after being given, according to a peer-reviewed observational study of about 9,000 people in Israel. Research also found the vaccine’s efficacy to be 91.3% up to six months after getting the second dose, Pfizer and BioNTech said. In response to a request for comment, Sinovac pointed to the results of Friday’s study. The lower protection from Sinovac’s single shot means the benefits of the vaccination campaign could take longer but health officials think some level of herd immunity will be reached by June or July. However, health professionals say the virus will probably be around indefinitely, given the potential for new variants, many of which are already prevalent in neighboring countries such as Brazil. They warn that further restriction and lockdowns could be required. Despite the surge, Chilean officials defend the vaccine, saying it is effective after the full regimen of two doses and is already helping to protect the elderly, making this surge less deadly. While severe cases and infections among older people have been dropping, countless Chileans let their guard down too soon, public-health experts say. “As a country, we trusted that, because of the vaccine, we were sort of out of it. But of course we aren’t,” said Mr. Jordán, a businessman and prominent mountaineer who has scaled Mt. Everest and maintained precautions after his first vaccine dose. Independent public-health experts say the Chilean government sent confusing messages as it celebrated the vaccine rollout, by far Latin America’s fastest, and eased social restrictions to help the economy. Police officers in Santiago enforced a curfew this month, as Chile’s capital went into lockdown again amid a surge in Covid-19 cases. Photo: Marcelo Hernandez/Getty Images Millions of Chileans worn out by the pandemic saw that as a green light to travel within the country during the Southern Hemisphere’s summer holidays. People flocked to bars, restaurants and crowded beaches, many not wearing masks. Theater resumed, with the virus sweeping through one play, infecting virtually all of the actors and killing two. Young people held house parties, even though such gatherings remained prohibited. Jaime Mañalich, who was health minister at the start of the pandemic, said the full two-dose regimen must be completed. “The fundamental message is that the start of a vaccination campaign is a very good thing, but you can’t relax the health measures,” he said. SHARE YOUR THOUGHTS What can other countries learn from Chile’s experience with vaccine rollout? Join the conversation below. Camila Moya, a 28-year-old doctor, found out just how little protection she had after receiving her first dose. Infected with Covid-19, she developed a cough that shot pains into her chest. She has recovered now, but still has trouble breathing. “You can’t relax with this virus,” she said. “Everything is uncertain.” After health authorities in China recently spoke about experimenting with different doses and possibly adding a third shot, health officials in Chile have begun weighing whether to provide Chileans with a third shot, said Rafael Araos, an adviser to Chile’s current health minister. “It is always an option,” said Mr. Araos, though details on the deliberations haven’t been made public. Chile began vaccinating in December, but didn’t ramp up the campaign until the start of February after receiving its first shipment of Sinovac’s CoronaVac vaccines, which account for about 90% of all the shots administered. More than 5 million Chileans, including 85% of those who are over 70 years of age, have received two shots. Government data shows a recent decline in elderly patients in hospital intensive-care units, with fewer dying. A nurse checked an intubated Covid-19 patient last week in a hospital ICU in Concepción, Chile. Photo: guillermo salgado/Agence France-Presse/Getty Images Dr. Rodrigo Cornejo, the head of the ICU at the University of Chile’s hospital, said that last year that more than a dozen close colleagues died of the virus. Since medical staff have been fully vaccinated, he hasn’t heard of any doctors dying from Covid-19, he said. In his intensive-care unit, patients used to be mostly older. Today, just six of the people in the 58 beds are over 70. Those patients, he said, became ill after receiving one shot of the vaccine or before getting full protection after the second dose, which takes two weeks. “The situation is dramatically different,” he said. “Today, the elderly are the exception in the intensive-care units.” Dr. Cornejo recalled recently holding the hand of a 29-year-old patient before he was put on a mechanical ventilator and pledging he would do all he could. “He cried, he told me he was really scared and asked what would happen,” said Dr. Cornejo. “He couldn’t understand that he was in this situation.” As restrictions eased at the start of the year, 26-year-old Benjamin de la Barra got together for meals with friends he hadn’t seen in months, though he hadn’t been vaccinated. They always complied with government rules stipulating how many people could get together, he said. In late January, he suddenly lost his sense of taste and couldn’t smell his morning coffee. He tested positive for Covid-19, along with his family. “Everyone felt there was a light at the end of the tunnel, that we were coming out of this. You felt freer and no longer restricted by the virus,” he said from Santiago, now in lockdown. “It’s surprising to be back in this position now.” Corrections & Amplifications Serbia is receiving China’s Sinopharm vaccine. An earlier version of this article incorrectly said Serbia is receiving the vaccine made by Sinovac. (Corrected on April 18) Write to Ryan Dube at ryan.dube@dowjones.com Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Appeared in the April 19, 2021, print edition as 'Chile Gets Dose of Reality.'
  12. I don't consider the news to be good regarding Sinovac. Chile has used it extensively and studied 10.5 million people who received it. They say after 1 shot you have only 16% protection, which is outrageously low in my opinion. Pfizer is said to have at least 80% after 1 shot. I hope that all the people who got Sinovac aren't loosening up their precautions, thinking that now they're safe. Even after 2 shots of Sinovac, the Chileans report just 67% efficacy. I would say that it's better than nothing but a long way from ideal. https://www.wsj.com/articles/first-dose-of-chinese-covid-19-vaccine-offers-little-protection-chile-learns-11618775502
  13. They actually just want you to get vaccinated and with the exception of the people at the VFG arena, they don't really care where you're from and it's not stealing. They are not getting the turnout they hoped for and they are encouraging anyone over 60 who hasn't had any vaccine yet to come. Here is proof of that from El Salto. The government would prefer anyone in that age category to come rather than end up in their hospitals.
×
×
  • Create New...